Definitive Contract 75A50123C00045
Award Date
9/29/23
Potential Completion Date
9/28/29
Potential Value
$126M
Awardee
PPD Development LP
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to PPD Development LP, a global contract research organization (CRO), to establish a high-throughput severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binding antibody immunoassay capability and test human serum samples. The $11,503,402.18 contract has a period of performance through November 22, 2021 and does not utilize a set-aside. PPD...
This is a $222,126,308 cost-plus-incentive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development LP, a global contract research organization (CRO). The contract supports a randomized, double-blind, placebo-controlled, multicenter Phase 2 clinical trial in the U.S. to evaluate the safety and efficacy of novel host-directed therapeutic candidates in hospitalized adults with acute respiratory distress syndrome (ARDS). The contract has an...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization (CRO). The contract, valued at $64,031,927.00, is for completing the ACTIV 2 study to support COVID-19 research. The contract is a cost-plus-fixed-fee type and does not have a set-aside designation. PPD Development LP is a subsidiary of Thermo Fisher...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...
This is a $75,173,993.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract provides comprehensive and rapid response services for NIAID's research programs related to HIV and other infectious diseases. This order falls under a larger $545 million Comprehensive and Rapid Response contract vehicle that...
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...
This is a $28,578,960 definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The contract is for clinical site monitoring services in support of NIAID's various clinical research programs, trials, and studies. It has a 10-year period of performance and was awarded on a full and open basis without a set-aside designation. The...
This is a $324,420.00 firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The contract is for research and development services related to clinical studies in the Blueprint MedTech program, including clinical study protocol development. The contract has a 5-year period of performance from June 17, 2024 to June 16, 2029, with a base period and two option units. PPD...
This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The $18,792,842.54 contract is for the Immune Tolerance Network - Clinical Site Monitoring Group, which involves comprehensive clinical trial and research support services such as regulatory affairs, clinical site monitoring,...
This is a federal contract award to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The $151,299.72 firm fixed-price delivery order was issued under the Medical Product Research and Development Indefinite Delivery Vehicle (IDV) with the U.S. Army Medical Command (MEDCOM). The contract does not have a set-aside designation. PPD Development LP provides comprehensive clinical trial and research support services to various federal...